Revolutionizing Preventive Medicine with AI Facial Biometrics: Medical Care Technologies Inc. (OTC Pink:MDCE) Leads the Charge
Medical Care Technologies (OTC Pink:MDCE) has unveiled its revolutionary AI Facial Age-Based Health Risk Estimator, a groundbreaking diagnostic tool that combines artificial intelligence with computer vision for preventive healthcare.
The platform analyzes facial biometric markers including micro-wrinkle density, skin elasticity, and tone variance to estimate biological age and assess risk for chronic conditions like cardiovascular disease and type 2 diabetes. The technology enables real-time, non-invasive screening through mobile apps, marking a shift from reactive to proactive healthcare.
This innovation positions MDCE to capitalize on the global preventive health market, which is projected to surpass $250 billion by 2030.
Medical Care Technologies (OTC Pink:MDCE) ha presentato il suo rivoluzionario AI Facial Age-Based Health Risk Estimator, uno strumento diagnostico innovativo che combina intelligenza artificiale e visione artificiale per la prevenzione sanitaria.
La piattaforma analizza marcatori biometrici facciali come densit脿 delle micro-rughe, elasticit脿 della pelle e variazioni di tonalit脿 per stimare l'et脿 biologica e valutare il rischio di patologie croniche quali malattie cardiovascolari e diabete di tipo 2. Questa tecnologia consente uno screening non invasivo e in tempo reale tramite app mobili, segnando una svolta dalla medicina reattiva a quella proattiva.
Questa innovazione posiziona MDCE per sfruttare il mercato globale della salute preventiva, previsto superare i 250 miliardi di dollari entro il 2030.
Medical Care Technologies (OTC Pink:MDCE) ha presentado su revolucionario AI Facial Age-Based Health Risk Estimator, una herramienta diagn贸stica innovadora que combina inteligencia artificial con visi贸n por computadora para la atenci贸n preventiva de la salud.
La plataforma analiza marcadores biom茅tricos faciales como densidad de microarrugas, elasticidad de la piel y variaci贸n del tono para estimar la edad biol贸gica y evaluar el riesgo de enfermedades cr贸nicas como enfermedades cardiovasculares y diabetes tipo 2. La tecnolog铆a permite un cribado no invasivo y en tiempo real a trav茅s de aplicaciones m贸viles, marcando un cambio de la atenci贸n reactiva a la proactiva.
Esta innovaci贸n posiciona a MDCE para aprovechar el mercado global de salud preventiva, que se proyecta superar谩 los 250 mil millones de d贸lares para 2030.
Medical Care Technologies (OTC Pink:MDCE)電� 鞚戈车歆�電リ臣 旎错摠韯� 牍勳爠鞚� 瓴绊暕頃� 順侅嫚鞝侅澑 歆勲嫧 霃勱惮鞚� AI Facial Age-Based Health Risk Estimator毳� 瓿店皽頄堨姷雼堧嫟. 鞚措姅 鞓堧癌 鞚橂 攵勳暭鞚� 須嶊赴鞝侅澑 旮办垹鞛呺媹雼�.
鞚� 頂岆灚韽检潃 氙胳劯 欤茧 氚�霃�, 頂茧秬 韮勲牓靹�, 韱� 氤�頇� 霌� 鞏缄荡鞚� 靸濎泊 歆�響滊ゼ 攵勳劃頃橃棳 靸濍頃欖爜 雮橃澊毳� 於旍爼頃橁碃 鞁槇甏� 歆堩櫂 氚� 鞝�2順� 雼闺嚚氤戧臣 臧欖潃 毵岇劚 歆堩櫂 鞙勴棙鞚� 韽夑皜頃╇媹雼�. 鞚� 旮办垹鞚� 氇皵鞚� 鞎膘潉 韱淀暣 鞁れ嫓臧� 牍勳龚鞀奠爜 瓴�靷�毳� 臧�電ロ晿瓴� 頃橃棳 氚橃潙鞝� 鞚橂鞐愳劀 鞓堧癌鞝� 鞚橂搿滌潣 鞝勴櫂鞚� 鞚橂頃╇媹雼�.
鞚� 順侅嫚鞚� MDCE臧� 旮�搿滊矊 鞓堧癌 瓯搓皶 鞁滌灔鞚� 瓿惦灥頃� 靾� 鞛堧姅 鞙勳箻鞐� 鞛堨溂氅�, 2030雲勱箤歆� 2500鞏� 雼煬毳� 齑堦臣頃� 瓴冹溂搿� 鞓堨儊霅╇媹雼�.
Medical Care Technologies (OTC Pink:MDCE) a d茅voil茅 son r茅volutionnaire AI Facial Age-Based Health Risk Estimator, un outil de diagnostic innovant qui combine intelligence artificielle et vision par ordinateur pour la sant茅 pr茅ventive.
La plateforme analyse des marqueurs biom茅triques faciaux tels que la densit茅 des micro-rides, l'茅lasticit茅 de la peau et la variation de ton pour estimer l'芒ge biologique et 茅valuer le risque de maladies chroniques comme les maladies cardiovasculaires et le diab猫te de type 2. Cette technologie permet un d茅pistage non invasif en temps r茅el via des applications mobiles, marquant une transition des soins r茅actifs aux soins proactifs.
Cette innovation positionne MDCE pour tirer parti du march茅 mondial de la sant茅 pr茅ventive, qui devrait d茅passer 250 milliards de dollars d'ici 2030.
Medical Care Technologies (OTC Pink:MDCE) hat seinen revolution盲ren AI Facial Age-Based Health Risk Estimator vorgestellt, ein bahnbrechendes Diagnosewerkzeug, das k眉nstliche Intelligenz mit Computer Vision f眉r pr盲ventive Gesundheitsvorsorge kombiniert.
Die Plattform analysiert biometrische Gesichtsmarker wie Mikofalten-Dichte, Hautelastizit盲t und Tonabweichungen, um das biologische Alter zu sch盲tzen und das Risiko f眉r chronische Erkrankungen wie Herz-Kreislauf-Erkrankungen und Typ-2-Diabetes zu bewerten. Die Technologie erm枚glicht eine Echtzeit- und nicht-invasive Untersuchung 眉ber mobile Apps und markiert einen Wandel von reaktiver zu proaktiver Gesundheitsversorgung.
Diese Innovation positioniert MDCE, um vom globalen Markt f眉r pr盲ventive Gesundheit zu profitieren, der voraussichtlich bis 2030 250 Milliarden US-Dollar 眉bersteigen wird.
- Innovative AI-powered diagnostic tool combining facial biometrics with preventive healthcare
- Mobile app deployment enables scalable, non-invasive screening solution
- Strategic entry into growing preventive health market projected at $250B by 2030
- Early-stage technology without proven clinical validation
- Potential regulatory hurdles for AI-based medical diagnostic tools
- Competitive market with established healthcare technology players
MESA, ARIZONA / / July 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is redefining the future of preventive healthcare with its cutting-edge AI Facial Age-Based Health Risk Estimator-a breakthrough diagnostic tool at the intersection of artificial intelligence, computer vision, and personalized medicine.
This sophisticated platform analyzes facial imagery to extract biometric markers such as micro-wrinkle density, skin elasticity, and tone variance, then applies machine learning algorithms to estimate biological age and assess predisposition to chronic conditions like cardiovascular disease and type 2 diabetes. The tool enables real-time, non-invasive screening by integrating visual facial data with predictive biomarkers, offering scalable diagnostics through mobile apps.
This innovation marks a fundamental shift in how preventive health is approached-moving away from reactive care and toward proactive, data-driven wellness management. With the global preventive health market projected to exceed
About Us
Medical Care Technologies Inc. (OTC Pink:MDCE) is a diversified technology-driven health and lifestyle company focused on revolutionizing preventive care and wellness through advanced AI solutions. Its core initiatives include real-time facial and skin diagnostics for early detection and health optimization.
MDCE is also the parent company of two incredible subsidiaries that you should inquire about:
Infinite Auctions, a premier marketplace for high-value sports memorabilia, including game-worn collectibles from legends like Michael Jordan, LeBron James, and Kobe Bryant.
AG真人官方 Game Used (RGU), an industry leader in game-used item authentication and photo-matching using proprietary AI image scanning technologies that boost trust, value, and liquidity across the collectibles space.
Together, these divisions reflect MDCE's multi-industry growth strategy-delivering technological innovation, entertainment, and authenticity at scale.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates, and projections and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Medical Care Technologies Inc. undertakes no obligation to update these statements in the future.
For more information, visit:
Investor Relations:
Investor & Media Contact:
Infinite Auctions / MDCE
[email protected]
SOURCE: (OTC PINK:MDCE) Medical Care Technologies Inc.
View the original on ACCESS Newswire
FAQ
What is Medical Care Technologies' (MDCE) new AI health technology?
How does MDCE's AI facial analysis technology work?
What medical conditions can MDCE's AI technology detect?
What is the market potential for MDCE's preventive health technology?
How will MDCE's technology be accessible to users?
